Cambridge-based drug company Moderna has begun a study that will test its COVID vaccine in children younger than 12, including babies as young as 6 months, the company said Tuesday.
The study is expected to enroll 6,750 healthy children in the United States and Canada.
“There’s a huge demand to find out about vaccinating kids and what it does,” said Dr. David Wohl, medical director of the vaccine clinic at the University of North Carolina, who is not involved the study.
In a separate study, Moderna is testing its vaccine in 3,000 children ages 12-17.
Many parents want protection for their children, and vaccinating children should help to produce
→ Continue reading at Boston - Business